Ipsen

By doing this, we strengthened Ipsen’s relevance by stripping it to its core and what matters most – business, patients and people. ... It was obvious that Ipsen have carried out a huge amount of work internally throughout 2019.

AstraZeneca Global Corporate Affairs

- - PMLiVE - PMLiVE

In-House Team of the Year

Until 2019, being seen as ‘relevant’ to key stakeholders was one of Ipsen’s biggest challenges, but we saw this as an opportunity to put the company on the map as ... By doing this, we strengthened Ipsen’s relevance by stripping it to its core

Revenue growth at Ipsen numbs pain of palovarotene calamity

Then, just last month, Ipsen said the drug had failed a futility test in its registrational MOVE trial, suggesting it was heading for failure. ... In the near-term, Ipsen’s late-stage R&D beyond palovarotene is focused mainly on line extensions for

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]